Skip to main content
TipRanks
Go Ultimate75% OFF

Bactiguard Holding AB (5JE) AI Stock Analysis

0 Followers
DE:5JE

Bactiguard Holding AB

(Frankfurt:5JE)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Improving Cash GenerationThe return to positive operating and free cash flow strengthens internal funding capacity and reduces reliance on external financing. If maintained, better cash conversion can support product development, partner implementation, and regulatory activity while providing greater resilience through normal business fluctuations.
Negative Factors
Unproven ProfitabilityDespite substantial improvement from earlier losses, the company has not yet demonstrated durable operating profitability or positive shareholder returns. Continued losses could limit internally funded growth, weaken confidence in the business model, and make results more sensitive to execution and adoption timing.

Bactiguard Holding AB (5JE) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%DE:5JE-7.12%EWG+1.23%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 47.15M
Dividend Yield
―
Average Volume (3M)
3,000
Price to Earnings (P/E)
82.5
Beta (1Y)
-0.26
Revenue Growth
2.23%
EPS Growth
―
Country
Germany
Employees
166
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Bactiguard Holding AB Business Overview & Revenue Model

Company Description

Bactiguard Holding AB (publ), a Swedish-based global medical technology company, specializes in developing and supplying innovative solutions designed to prevent infections. Its primary objective is to mitigate healthcare-associated infections (HAIs)...

Bactiguard Holding AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:5JE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:GETI.BSE:GETI.B67NeutralSEK 76.26B26.649.13%1.72%-3.90%37.73%
SE:SEZISE:SEZI55NeutralSEK 518.02M-5.23-35.44%―18.56%28.11%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:INTEG.BSE:INTEG.B45NeutralSEK 240.54M-5.66-20.71%―1.43%4.98%
SE:OSSDSE:OSSD45NeutralSEK 352.90M-6.59――-11.89%-11.85%

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%DE:5JESE:GETI.BSE:SEZISE:INTEG.BSE:PROSE:OSSDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:5JE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:5JEBactiguard Holding AB1.24-0.11-8.49%
SE:GETI.BGetinge AB (UK)276.8071.2534.66%
SE:SEZISenzime AB3.25-1.81-35.87%
SE:INTEG.BIntegrum AB Class B8.14-0.79-8.85%
SE:PROPromimic AB9.00-8.05-47.21%
SE:OSSDOssDsign AB2.98-7.42-71.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.